Suppr超能文献

一种新型胶原蛋白基复合材料可为多种手术适应症提供有效的止血效果:一项随机对照试验的结果。

A novel collagen-based composite offers effective hemostasis for multiple surgical indications: Results of a randomized controlled trial.

出版信息

Surgery. 2001 Apr;129(4):445-50. doi: 10.1067/msy.2001.112365.

Abstract

BACKGROUND

Intraoperative bleeding is ubiquitous during open surgical procedures and uniformly effective hemostasis remains elusive. We conducted a randomized controlled trial to determine the effectiveness of a novel collagen-based composite (CoStasis Surgical Hemostat) compared with standard methods of hemostasis during general, hepatic, cardiac, and orthopedic operations.

METHODS

Hemostatic treatment was assigned randomly to 347 subjects; 318 subjects (167 CoStasis, 151 controls) underwent operation, received treatment, and provided hemostatic success data. CoStasis was applied to the bleeding site without manual pressure as a sprayable liquid composite of bovine microfibrillar collagen, bovine thrombin, and autologous plasma. Manual compression was used as the control hemostat. Hemostatic success was achieved if bleeding had ceased completely within 10 minutes (3 minutes for cardiac subjects). The time to controlled bleeding (ie, slight oozing) and time to complete hemostasis were recorded for all subjects.

RESULTS

Hemostatic success was achieved in more than 90% (153/167) of CoStasis subjects compared with 58% (88/151) of control subjects (P =.01). Superior hemostatic effectiveness with CoStasis was realized in every surgical specialty: general (77/79 vs 49/75, P =.01), hepatic (38/39 vs 20/29, P =.01), cardiac (28/37 vs 17/37, P =.02), and orthopedic (10/12 vs 2/10, P =.01). The duration of bleeding was also significantly shorter with CoStasis. The median time to controlled bleeding (42 seconds vs 150 seconds, P =.0001) and time to complete hemostasis (75 seconds vs 252 seconds, P =.0001) were both markedly longer with the control intervention. There were no serious adverse events related to the use of CoStasis.

CONCLUSIONS

CoStasis is more effective at controlling and stopping diffuse intraoperative bleeding than standard methods of hemostasis in 4 distinct surgical indications representing a wide variety of operative interventions.

摘要

背景

在开放手术过程中,术中出血普遍存在,而始终有效的止血方法仍难以实现。我们进行了一项随机对照试验,以确定一种新型胶原蛋白基复合材料(CoStasis手术止血剂)与普通外科、肝脏、心脏和骨科手术中标准止血方法相比的有效性。

方法

对347名受试者进行随机止血治疗;318名受试者(167名使用CoStasis,151名作为对照)接受手术、治疗并提供止血成功数据。CoStasis作为一种由牛微原纤维胶原蛋白、牛凝血酶和自体血浆组成的可喷雾液体复合材料,在不进行手动按压的情况下应用于出血部位。手动压迫用作对照止血方法。如果出血在10分钟内(心脏手术受试者为3分钟)完全停止,则止血成功。记录所有受试者实现可控出血(即轻微渗血)的时间和完全止血的时间。

结果

CoStasis组超过90%(153/167)的受试者实现了止血成功,而对照组为58%(88/151)(P = 0.01)。在每个外科专科中,CoStasis均显示出卓越的止血效果:普通外科(77/79对49/75,P = 0.01)、肝脏外科(38/39对20/29,P = 0.01)、心脏外科(28/37对17/37,P = 0.02)和骨科(10/12对2/10,P = 0.01)。使用CoStasis时,出血持续时间也显著缩短。对照干预组实现可控出血的中位时间(42秒对150秒,P = 0.0001)和完全止血的时间(75秒对252秒,P = 0.0001)均明显更长。未发现与使用CoStasis相关的严重不良事件。

结论

在代表各种手术干预的4种不同手术指征中,CoStasis在控制和停止术中弥漫性出血方面比标准止血方法更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验